Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumes:
Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v21.i7.70
pages 703-711

Inhibitory Effect of Five Ganoderma Species (Agaricomycetes) against Key Digestive Enzymes Related to Type 2 Diabetes Mellitus

Shao-Dan Chen
State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangdong Institute of Microbiology, Guangzhou 510070, China; Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, 510070, China
Tian-Qiao Yong
State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangdong Institute of Microbiology, Guangzhou 510070, China; Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, 510070, China
Yi-fan Zhang
State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangdong Institute of Microbiology, Guangzhou 510070, China; Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, 510070, China
Hui-Ping Hu
State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangdong Institute of Microbiology, Guangzhou 510070, China; Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, 510070, China
Yi-Zhen Xie
Guangdong Institute of Microbiology, State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangzhou, P.R. China; Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, P.R. China

SINOPSIS

Ganoderma mushrooms are widely used in clinical therapies and functional foods. The antidiabetic effect of Ganoderma has become a research hot spot in recent decades. To search for a superior antidiabetic Ganoderma extract, five common Ganoderma species (G. lucidum, G. sinense, G. tsugae, G. applanatum, and G. leucocontextum) were investigated. A total of 10 fractions, including a total triterpenes fraction and a crude polysaccharides fraction for each, were prepared for further assays. Activities of α-glucosidase and α-amylase are inhibited dominantly by triterpenes from all five Ganoderma species rather than the polysaccharides. G. lucidum triterpenes inhibits α-glucosidase and α-amylase most significantly with IC50 values of 10.02 ± 0.95 µg/mL and 31.82 ± 4.30 µg/mL. Even more, triterpenes content was positively correlated with anti−α-glucosidase and anti−α-amylase activities. Therefore, triterpenes were considered to be the active compounds in inhibiting α-glucosidase and α-amylase activity. It is hoped that the results will provide more systematic information for the application of Ganoderma in the functional food and traditional medicine industries in the future.

REFERENCIAS

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.

  2. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37:S14-80.

  3. Rios JL, Francini F, Schinella GR. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81(12/13):975-94.

  4. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77-82.

  5. Aryangat AV, Gerich JE. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag. 2010;6:145-55.

  6. Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med J. 2012;124:1-8.

  7. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119:351-7.

  8. Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am J Med Sci. 2012;343:17- 20.

  9. Su CH, Lai MN, Ng LT. Inhibitory effects of medicinal mushrooms on a-amylase and a-glucosidase-enzymes related to hyperglycemia. Food Funct. 2013;4(4):644-9.

  10. Lo HC, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms. 2011;13(5):401-26.

  11. Paterson RRM. Ganoderma-a therapeutic fungal biofactory. Phytochemistry. 2006;67:1985-2001.

  12. Ma HT, Hsieh JF, Chen ST. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 2015;114:109-13.

  13. Yang BK, Jung YS, Song, CH. Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo-polymers in streptozotocin-induced diabetic rats. Phytother Res. 2007;21(11):1066-9.

  14. Jung SH, Lee YS, Shim SH, Lee S, Shin KH, Kim JS, Kim YS, Kang SS. Inhibitory effects of Ganoderma applana- tum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Phytother Res. 2005;19(6):477-80.

  15. Wang K, Bao L, Ma K, Zhang JJ, Chen BS, Han JJ, Ren JW, Luo HJ, Liu HW. A novel class of alpha-glucosidase and HMG- CoA reductase inhibitors from Ganoderma leucocontextum and the anti-diabetic properties of ganomycin I in KK-A(y) mice. Eur J Med Chem. 2017;127:1035-46.

  16. Chen SD, Yong TQ, Xiao C, Su JY, Zhang YF, Jiao CW, Xie YZ. Pyrrole alkaloids and ergosterols from Grifola frondosa exert anti-a-glucosidase and anti-proliferative activities. J Funct Foods. 2018;43:196-205.

  17. Trinh, BTD, Staerk D, Jager AK. Screening for potential a-glucosidase and a-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes. J Ethnopharmacol. 2016;186:189-95.

  18. Pirian K, Moein S, Sohrabipour J, Rabiei R, Blomster J. Antidiabetic and antioxidant activities of brown and red macroalgae from the Persian Gulf. J Appl Phycol. 2017;29(6):3151-59.

  19. Li BM, Liu C, Wang HQ, Chen RY. Studies on the determination method of total triterpenoids in Ganoderma lucidum. China J Chin Mater Med. 2007;32(12):1234-36.

  20. Tatsuga M, Akio M, Norimasa I, Tokifumi M, Shin-Ichiro N, Lee YC. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem. 2005;339:69-72.

  21. Baby S, Johnson AJ, Govindan B. Secondary metabolites from Ganoderma. Phytochemistry. 2015;114:66-101.

  22. Chen XQ, Zhao J, Chen LX, Wang SF, Wang Y, Li SP. Lanostane triterpenes from the mushroom Ganoderma resinaceum and their inhibitory activities against alpha-glucosidase. Phytochemistry. 2018;149:103-15.

  23. Chen BS, Tian J, Zhang JJ, Wang K, Liu L, Yang B, Bao L, Liu HW. Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and alpha-glucosidase. Fitoterapia. 2017;120:6-16.

  24. Wang K, Bao L, Xiong WP, Ma K, Han JJ, Wang WZ, Yin WB, Liu HW. Lanostane triterpenes from the Tibetan medicinal mushroom Ganoderma leucocontextum and their inhibitory effects on HMG-CoA reductase and alpha-glucosidase. J Nat Prod. 2015;78(8):1977-89.

  25. Gill BS, Sharma P, Kumar R, Kumar S. Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling. Tumour Biol. 2016;37:2789-804.

  26. Rios JL, Andujar I, Recio MC, Giner RM. Lanostanoids from fungi: a group of potential anticancer compounds. J Nat Prod. 2012;75:2016-44.

  27. Wu JG, Kan YJ, Wu YB, Yi J, Chen TQ, Wu JZ. Hepatoprotective effect of ganoderma triterpenoids against oxidative damage induced by tert-butyl hydroperoxide in human hepatic HepG2 cells. Pharm Biol (Abingdon, UK). 2016;54:919-29.

  28. Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. 1998;46:1607-12.

  29. Rios JL. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 2011;77:681-91.

  30. Wu T, Xu B. Antidiabetic and antioxidant activities of eight medicinal mushroom species from China. In J Med Mushrooms. 2015;17(2):129-40.

  31. Fatmawati S, Kurashiki K, Takeno S, Kim YU, Shimizu K, Sato M, Imaizumi K, Takahashi K, Kamiya S, Kaneko S, Kondo R. The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum. Phytother Res. 2009;23(1):28-32.

  32. Tang X, Cai W, Xu B. Comparison of the chemical profiles and antioxidant and antidiabetic activities of extracts from two Ganoderma species (Agaricomycetes). Int J Med Mushrooms. 2016;18(7):609-20.

  33. Zhao XR, Huo XK, Dong PP, Wang C, Huang SS, Zhang BJ, Zhang HL, Deng S, Liu KX, Ma XC. Inhibitory effects of highly oxygenated lanostane derivatives from the fungus Ganoderma lucidum on P-Glycoprotein and a-Glucosidase. J Nat Prod. 2015;78(8):1868-76.

  34. Fatmawati S, Kondo R, Shimizu K. Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as a-glucosidase inhibitors. Bioorg Med Chem Letts. 2013;23(21):5900-3.

  35. Meng X, Liang H, Luo L. Antitumor polysaccharides from mushrooms: a review on thestructural characteristics, antitumor mechanisms and immunomodulating activities. Carbohydr Res. 2016;424:30-41.

  36. Huang X, Nie S. The structure of mushroom polysaccharides and their beneficial role in health. Food Funct. 2015;10(6): 3205-17.

  37. Xu S, Dou Y, Ye B, Wu Q, Wang Y, Hu M, Ma F, Rong X, Guo J. Ganoderma lucidum polysaccharides improve insulin sensitivity by regulating inflammatory cytokines and gut microbiota composition in mice. J Funct Foods. 2017;38:545-52.

  38. Zhu KX, Nie SP, Li C. Ganoderma atrum polysaccharide improves aortic relaxation in diabetic rats via PI3K/Akt pathway. Carbohydr Polymers. 2014;103:520-7.

  39. Xiao C, Wu Q, Zhang J, Xie Y, Cai W, Tan J. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down- regulated hepatic glucose regulatory enzymes in diabetic mice. J Ethnopharmacol. 2017;196:47-57.

  40. Xiao C, Wu Q, Cai W, Tan J, Yang X, Zhang J. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Arch Pharm Res. 2012;35(10):1793-801.


Articles with similar content:

Antimelanogenesis and Anti-Inflammatory Activity of Selected Culinary-Medicinal Mushrooms
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 2
Yee Shin Tan, Hazwani Mat Saad, Kae Shin Sim
Species of Genus Ganoderma (Agaricomycetes) Fermentation Broth: A Novel Antioxidant and Antimicrobial Agent
International Journal of Medicinal Mushrooms, Vol.18, 2016, issue 5
Mirjana Stajić, Jelena Vukojević, Marijana Kosanic, Jasmina Ćilerdžić, Branislav Ranković
Antioxidant Potential of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) Cultivated on Artocarpus heterophyllus Sawdust Substrate in India
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 12
Uma Maheshwari, Merlin Rajesh Lal, P. Rani, Sreeram Krishnan
The Antioxidant Properties, Tyrosinase and α-Glucosidase Inhibitory Activities of Phenolic Compounds in Different Extracts from the Golden Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 9
Hong Gao, Chaomin Yin, Chunyou Liu, Xiuzhi Fan, Defang Shi, Wei Cheng, Zhe Fan, Fen Yao
Optimization of Liquid Fermentation Medium for Production of Inonotus sanghuang (Higher Basidiomycetes) Mycelia and Evaluation of their Mycochemical Contents and Antioxidant Activities
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 7
Kun Xu, Ai-Rong Song, Xue-Mei Tian, Lean-Teik Ng, Yu-Cheng Dai